Supernus Pharmaceuticals, Inc.
Method of treatment of attention deficit/hyperactivity disorder (ADHD)

Last updated:

Abstract:

The invention comprises a method for treatment of ADHD or ADHD-related disorders by a pharmaceutical agent exhibiting combined serotonergic or noradrenergic reuptake transporters and monoamine receptor activity.

Status:
Grant
Type:

Utility

Filling date:

6 Jun 2017

Issue date:

10 May 2022